PharmStockPharmacy Stock

Indinavir
Indinavir

2.5
A generic medicine indicated for HIV. Inhibits viral enzymes to restrict viral replication and progression.
Ingredient
Indinavir
Category
HIV Management
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Indinavir
Reference Brand
Crixivan
Product Origin
Generic Product
Product Form
Capsule
Regulatory Classification
Prescription Only Medicine
Primary Category
Antivirals
Product Category
HIV Protease Inhibitor
Pharmacological Class
Antiretroviral
Manufacturer Description
Formulated to alleviate retroviral disease to support immune cells and target active viral protein synthesis.
Mechanism of Action
Binds reversibly to the active site of HIV protease, stopping protein cleavage and producing immature, non-infectious virus particles.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
8 hours
Contraindications
Severe renal calculi history, Concurrent use of midazolam or ergot derivatives
Severe Adverse Events
Acute kidney injury — requires immediate medical attention, Severe hemolytic anemia — requires immediate medical attention
Common Side Effects
Nausea, Abdominal pain, Taste perversion
Uncommon Side Effects
Nephrolithiasis, Indirect hyperbilirubinemia, Dry skin
Drug Interactions
Rifampin, Sildenafil, St. John's Wort
Pregnancy Safety Warnings
TGA Category C: Safe in pregnancy under combined therapy. Breastfeeding: Contraindicated to prevent transmission.
Age Restrictions
Approved for children over four years and adults.
Storage Guidelines
Store below 25°C. Protect from moisture.
Information related to Indinavir is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to access Blood Thinners Australia - Pradaxa Australia